Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-014001
Filing Date
2026-03-31
Accepted
2026-03-31 14:02:37
Documents
73
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 1651503
2 EX-3.2 ex3-2.htm EX-3.2 172099
3 EX-10.17 ex10-17.htm EX-10.17 149251
4 EX-10.19 ex10-19.htm EX-10.19 78431
5 EX-21.1 ex21-1.htm EX-21.1 3658
6 EX-23.1 ex23-1.htm EX-23.1 5548
7 EX-31.1 ex31-1.htm EX-31.1 14839
8 EX-31.2 ex31-2.htm EX-31.2 15091
9 EX-32.1 ex32-1.htm EX-32.1 7439
10 EX-32.2 ex32-2.htm EX-32.2 4824
11 GRAPHIC report_001.jpg GRAPHIC 8043
  Complete submission text file 0001493152-26-014001.txt   6543135

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE mira-20251231.xsd EX-101.SCH 36472
13 XBRL CALCULATION FILE mira-20251231_cal.xml EX-101.CAL 54861
14 XBRL DEFINITION FILE mira-20251231_def.xml EX-101.DEF 156913
15 XBRL LABEL FILE mira-20251231_lab.xml EX-101.LAB 381664
16 XBRL PRESENTATION FILE mira-20251231_pre.xml EX-101.PRE 307047
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 669689
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: 10-K | Act: 34 | File No.: 001-41765 | Film No.: 26820360
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)